AMBER LANGSTON: Open Payments
NPI 1437517877 · BUCKEYE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Astellas Pharma US Inc | 1 | $22 |
| Corcept Therapeutics | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: AIRSUPRA, Ozempic, Wegovy, Veozah, Korlym, ZORYVE, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
